AssayIndex
Reports by quarter

Reports submitted in 2026-Q1 · page 13

Rule AX-R12 added. Dataset v2 schema published. Median purity for the quarter is 99.22 % area, n=806. Read the 2026-Q1 state-of-the-index report →

806 records21 pagesmedian on this page 99.13 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043215GHRP-6SGNSGN-2510-P8974Janoshik2026-Q198.521.66107.4Buyer-sourced0FAIL
AX-2026-042946SemaglutideMKMMKM-2510-S3812Medutest2026-Q198.716.5698.3Buyer-sourced1FAIL
AX-2026-042932SelankMKMMKM-2512-T3523Nordanalyt2026-Q199.818.14103.0Buyer-sourced0PASS
AX-2026-042852TirzepatideGGPepsGGPE-2510-L2662PeptideMeter2026-Q198.084.34—Buyer-sourced0PASS
AX-2026-042646SemaglutideSWBSWB-2512-L7774PeptideMeter2026-Q197.935.1492.0Buyer-sourced2MARGINAL
AX-2026-0423065-Amino-1MQTFCTFC-2508-L2057Medutest2026-Q199.755.49—Buyer-sourced1FAIL
AX-2026-042279SemaglutideTFCTFC-2602-H9925Medutest2026-Q199.411.58104.1Buyer-sourced0PASS
AX-2026-041849BPC-157GSPGSP-2508-H3518VendorInvestigate2026-Q198.832.97—Buyer-sourced0PASS
AX-2026-041628SelankFGPFGP-2511-D8133PeptideMeter2026-Q199.825.9198.3Buyer-sourced0PASS
AX-2026-041492SemaglutideQSCQSC-2509-Y6202Janoshik2026-Q199.595.1390.5Buyer-sourced1FAIL
AX-2026-043408CJC-1295 (no DAC)WXTWXT-2511-N3100Janoshik2026-Q197.894.34—Buyer-sourced1FAIL
AX-2026-043199ExenatideGL BiochemGLBI-2509-A7833Janoshik2026-Q198.143.96105.8Buyer-sourced0PASS
AX-2026-042975MK-677 (Ibutamoren mesylate)MKMMKM-2509-T3949PeptideMeter2026-Q199.233.69—Laboratory-retained0FAIL
AX-2026-042853TirzepatideGGPepsGGPE-2510-L2662Janoshik2026-Q198.354.58100.6Buyer-sourced0PASS
AX-2026-042851TirzepatideGGPepsGGPE-2510-L2662Janoshik2026-Q198.203.88105.9Buyer-sourced0PASS
AX-2026-041940SemaxSinoPepSNP-2601-U4736Janoshik2026-Q199.357.1491.7Buyer-sourced1MARGINAL
AX-2026-041254SurvodutideWWBWWB-2510-R2141VendorInvestigate2026-Q199.445.79106.8Buyer-sourced0PASS
AX-2026-043587SS-31 (Elamipretide)SIGSIG-2512-6369Janoshik2026-Q199.256.28—Buyer-sourced0PASS
AX-2026-043109EpitalonKPKP-2508-Y5884Janoshik2026-Q198.398.2499.8Buyer-sourced0FAIL
AX-2026-042455SemaglutideHomopeptideHOMO-2511-C4492Janoshik2026-Q199.044.57—Buyer-sourced0PASS
AX-2026-042373SemaxHomopeptideHOMO-2601-D3090Janoshik2026-Q198.907.61—Buyer-sourced1MARGINAL
AX-2026-042194TB-500JEEPJEEP-2510-R9238PeptideMeter2026-Q199.424.8891.9Buyer-sourced2MARGINAL
AX-2026-041497SemaglutideQSCQSC-2509-Y6202Janoshik2026-Q199.184.9197.6Buyer-sourced0PASS
AX-2026-041372IpamorelinWWBWWB-2601-C3477VendorInvestigate2026-Q199.526.17—Buyer-sourced0PASS
AX-2026-041280TirzepatideWWBWWB-2601-J2662Medutest2026-Q199.224.80—Buyer-sourced0PASS
AX-2026-043562LiraglutideSIGSIG-2508-6459Medutest2026-Q198.575.7488.6Buyer-sourced1MARGINAL
AX-2026-043511SemaglutideSIGSIG-2511-5925PeptideMeter2026-Q198.503.09—Buyer-sourced0PASS
AX-2026-043406Melanotan IIWXTWXT-2511-P3680VendorInvestigate2026-Q198.993.7798.6Buyer-sourced0PASS
AX-2026-043054RetatrutideKPKP-2511-K4818Medutest2026-Q197.763.9493.6Buyer-sourced0PASS
AX-2026-042977MK-677 (Ibutamoren mesylate)MKMMKM-2509-T3949Janoshik2026-Q198.983.5393.6Buyer-sourced0FAIL
AX-2026-042655CJC-1295 (no DAC)SWBSWB-2512-S8187Nordanalyt2026-Q199.074.03—Buyer-sourced0PASS
AX-2026-042555TirzepatideHJHJ-2508-P6487Kestrel2026-Q199.594.34—Buyer-sourced0PASS
AX-2026-042404RetatrutideHomopeptideHOMO-2601-J3763Nordanalyt2026-Q198.905.3093.4Buyer-sourced0PASS
AX-2026-042361SemaxHomopeptideHOMO-2602-S3200Janoshik2026-Q199.918.7091.5Buyer-sourced0PASS
AX-2026-042269SemaglutideTFCTFC-2602-H9925Nordanalyt2026-Q199.321.6999.8Buyer-sourced0PASS
AX-2026-042100SemaxJEEPJEEP-2602-C8195Janoshik2026-Q199.498.3991.4Buyer-sourced0PASS
AX-2026-042077Melanotan IIHYBHYB-2510-R7319PeptideMeter2026-Q199.933.91—Buyer-sourced0PASS
AX-2026-041903SemaglutideSinoPepSNP-2509-A4337Janoshik2026-Q198.705.33—Buyer-sourced0PASS
AX-2026-041582SelankQSCQSC-2601-N7209Medutest2026-Q199.936.6096.4Buyer-sourced0PASS
AX-2026-041468AOD-9604QYBQYB-2508-E5277Medutest2026-Q199.593.8094.8Buyer-sourced0PASS